COMPANY
Eli Lilly Nederland B.V.
Eli Lilly Nederland B.V.: marketing authorisation holder for Dulaglutide, Teriparatide, Tirzepatide, as stated by public registers.
Also written as: ELI LILLY NEDERLAND B.V..
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Dulaglutide | Trulicity (EMEA/H/C/002825), Authorised Regulator EMA |
|---|---|
| Dulaglutide | TRULICITY 0.75 MG SOLUTION FOR INJECTION IN PRE FILLED PEN, PLGB 14895/0259, Authorised Regulator MHRA |
| Dulaglutide | TRULICITY 1.5 MG SOLUTION FOR INJECTION IN PRE FILLED PEN, PLGB 14895/0260, Authorised Regulator MHRA |
| Dulaglutide | TRULICITY 3 MG SOLUTION FOR INJECTION IN PRE FILLED PEN, PLGB 14895/0261, Authorised Regulator MHRA |
| Dulaglutide | TRULICITY 4.5 MG SOLUTION FOR INJECTION IN PRE FILLED PEN, PLGB 14895/0262, Authorised Regulator MHRA |
| Teriparatide | Forsteo (EMEA/H/C/000425), Authorised Regulator EMA |
| Teriparatide | FORSTEO 20 MICROGRAMS/80 MICROLITERS SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0243, Authorised Regulator MHRA |
| Tirzepatide | Mounjaro (EMEA/H/C/005620), Authorised Regulator EMA |
| Tirzepatide | MOUNJARO 10 MG KWIKPEN SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0343, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 10 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0321, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 10 MG SOLUTION FOR INJECTION IN VIAL, PLGB 14895/0334, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 12.5 MG KWIKPEN SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0344, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 12.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0322, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 12.5 MG SOLUTION FOR INJECTION IN VIAL, PLGB 14895/0335, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 15 MG KWIKPEN SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0345, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 15 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0323, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 15 MG SOLUTION FOR INJECTION IN VIAL, PLGB 14895/0336, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 2.5 MG KWIKPEN SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0340, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 2.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0317, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 2.5 MG SOLUTION FOR INJECTION IN VIAL, PLGB 14895/0331, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 5 MG KWIKPEN SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0341, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0318, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 5 MG SOLUTION FOR INJECTION IN VIAL, PLGB 14895/0332, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 7.5 MG KWIKPEN SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0342, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 7.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN, PLGB 14895/0320, Authorised Regulator MHRA |
| Tirzepatide | MOUNJARO 7.5 MG SOLUTION FOR INJECTION IN VIAL, PLGB 14895/0333, Authorised Regulator MHRA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.